Constance Susan Houck, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pediatrics | 17 | 2021 | 3622 | 1.420 |
Why?
|
| Anesthesia | 7 | 2019 | 1596 | 0.960 |
Why?
|
| Societies, Medical | 6 | 2021 | 3955 | 0.940 |
Why?
|
| Surgical Procedures, Operative | 7 | 2020 | 1937 | 0.890 |
Why?
|
| Organizational Policy | 4 | 2021 | 434 | 0.860 |
Why?
|
| Urologic Surgical Procedures | 6 | 2019 | 299 | 0.850 |
Why?
|
| Laparoscopy | 9 | 2019 | 2056 | 0.800 |
Why?
|
| Anesthetics | 2 | 2019 | 525 | 0.790 |
Why?
|
| Anesthetics, Local | 6 | 2019 | 1005 | 0.790 |
Why?
|
| Anesthesiology | 5 | 2020 | 1137 | 0.700 |
Why?
|
| Bupivacaine | 3 | 2019 | 412 | 0.690 |
Why?
|
| Water-Electrolyte Balance | 1 | 2020 | 326 | 0.620 |
Why?
|
| Body Temperature Regulation | 1 | 2020 | 292 | 0.600 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2018 | 236 | 0.540 |
Why?
|
| Airway Management | 1 | 2020 | 326 | 0.530 |
Why?
|
| Neurotoxicity Syndromes | 2 | 2019 | 303 | 0.520 |
Why?
|
| Morphine | 2 | 2019 | 658 | 0.520 |
Why?
|
| Hospitals, Pediatric | 4 | 2023 | 1876 | 0.510 |
Why?
|
| Quality Improvement | 4 | 2020 | 3858 | 0.500 |
Why?
|
| Hyperkalemia | 1 | 2017 | 233 | 0.480 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2020 | 592 | 0.460 |
Why?
|
| Pain, Postoperative | 5 | 2019 | 1763 | 0.450 |
Why?
|
| Urologic Diseases | 1 | 2016 | 247 | 0.440 |
Why?
|
| Analgesics, Opioid | 6 | 2019 | 3837 | 0.430 |
Why?
|
| Nephrectomy | 1 | 2017 | 949 | 0.390 |
Why?
|
| United States Food and Drug Administration | 2 | 2019 | 1669 | 0.390 |
Why?
|
| Pain | 8 | 2023 | 5096 | 0.380 |
Why?
|
| Renal Insufficiency | 1 | 2017 | 809 | 0.380 |
Why?
|
| Specialties, Surgical | 3 | 2020 | 393 | 0.370 |
Why?
|
| Child | 39 | 2023 | 80863 | 0.360 |
Why?
|
| Robotics | 6 | 2013 | 826 | 0.350 |
Why?
|
| Resuscitation Orders | 3 | 2018 | 271 | 0.340 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 1514 | 0.340 |
Why?
|
| Inpatients | 1 | 2021 | 2561 | 0.340 |
Why?
|
| Developing Countries | 1 | 2022 | 2901 | 0.340 |
Why?
|
| Anesthesia, General | 1 | 2017 | 1185 | 0.330 |
Why?
|
| Developmental Disabilities | 1 | 2017 | 1516 | 0.300 |
Why?
|
| Pain Measurement | 6 | 2019 | 3577 | 0.300 |
Why?
|
| Intubation, Intratracheal | 3 | 2010 | 1359 | 0.280 |
Why?
|
| Quality Assurance, Health Care | 1 | 2017 | 2179 | 0.270 |
Why?
|
| Drug Therapy | 1 | 2020 | 504 | 0.270 |
Why?
|
| Codeine | 1 | 2016 | 51 | 0.270 |
Why?
|
| Analgesics, Non-Narcotic | 3 | 2016 | 371 | 0.230 |
Why?
|
| Conscious Sedation | 4 | 2013 | 535 | 0.220 |
Why?
|
| Tetrodotoxin | 1 | 2004 | 245 | 0.210 |
Why?
|
| Emergencies | 1 | 2020 | 1222 | 0.210 |
Why?
|
| Administration, Cutaneous | 1 | 2005 | 716 | 0.210 |
Why?
|
| Models, Biological | 1 | 2019 | 9505 | 0.210 |
Why?
|
| Anesthesia, Local | 1 | 2005 | 278 | 0.210 |
Why?
|
| Brain | 2 | 2022 | 27438 | 0.210 |
Why?
|
| Endothelin-1 | 1 | 2004 | 302 | 0.210 |
Why?
|
| Analgesia | 3 | 2023 | 461 | 0.200 |
Why?
|
| Anesthesia, Caudal | 1 | 2002 | 33 | 0.200 |
Why?
|
| Neurons, Afferent | 1 | 2004 | 498 | 0.190 |
Why?
|
| Advisory Committees | 2 | 2018 | 797 | 0.190 |
Why?
|
| Medical Staff Privileges | 1 | 2020 | 13 | 0.180 |
Why?
|
| Humans | 58 | 2023 | 768451 | 0.180 |
Why?
|
| Health Resources | 2 | 2020 | 950 | 0.180 |
Why?
|
| History, 20th Century | 2 | 2020 | 2772 | 0.180 |
Why?
|
| Physicians | 1 | 2019 | 4615 | 0.180 |
Why?
|
| Infant | 17 | 2023 | 36497 | 0.180 |
Why?
|
| Infant, Newborn | 10 | 2020 | 26395 | 0.180 |
Why?
|
| Iatrogenic Disease | 1 | 2013 | 552 | 0.180 |
Why?
|
| Nebulizers and Vaporizers | 2 | 2019 | 139 | 0.180 |
Why?
|
| General Surgery | 3 | 2019 | 1714 | 0.170 |
Why?
|
| Anesthesia, Epidural | 1 | 2002 | 233 | 0.170 |
Why?
|
| Referral and Consultation | 2 | 2014 | 3629 | 0.170 |
Why?
|
| Tolmetin | 2 | 1996 | 24 | 0.170 |
Why?
|
| Transportation of Patients | 1 | 2000 | 176 | 0.170 |
Why?
|
| Air Ambulances | 1 | 2000 | 93 | 0.160 |
Why?
|
| Premedication | 1 | 2010 | 246 | 0.160 |
Why?
|
| Polypharmacy | 1 | 2021 | 307 | 0.160 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2013 | 628 | 0.160 |
Why?
|
| Hypnotics and Sedatives | 5 | 2023 | 1188 | 0.160 |
Why?
|
| Perioperative Care | 2 | 2017 | 1046 | 0.150 |
Why?
|
| Specialty Boards | 1 | 2020 | 236 | 0.150 |
Why?
|
| Kidney Pelvis | 2 | 2011 | 195 | 0.150 |
Why?
|
| Regional Medical Programs | 1 | 2018 | 66 | 0.150 |
Why?
|
| Sucrose | 2 | 2016 | 159 | 0.150 |
Why?
|
| Practice Guidelines as Topic | 4 | 2021 | 7451 | 0.150 |
Why?
|
| United States | 12 | 2023 | 73121 | 0.150 |
Why?
|
| Thoracic Vertebrae | 1 | 2002 | 613 | 0.140 |
Why?
|
| Organizational Innovation | 1 | 2020 | 540 | 0.140 |
Why?
|
| Certification | 1 | 2020 | 419 | 0.140 |
Why?
|
| Aerosols | 1 | 2019 | 637 | 0.140 |
Why?
|
| Social Justice | 1 | 2021 | 486 | 0.130 |
Why?
|
| Organizational Culture | 1 | 2020 | 510 | 0.130 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 2016 | 43 | 0.130 |
Why?
|
| Anesthesia Recovery Period | 1 | 2017 | 155 | 0.130 |
Why?
|
| Insufflation | 1 | 2016 | 64 | 0.130 |
Why?
|
| Intraoperative Care | 1 | 2019 | 772 | 0.130 |
Why?
|
| Medication Errors | 1 | 2021 | 783 | 0.130 |
Why?
|
| Anesthetics, General | 1 | 2017 | 152 | 0.120 |
Why?
|
| Penis | 1 | 2016 | 213 | 0.120 |
Why?
|
| Drug Administration Schedule | 2 | 2021 | 4861 | 0.120 |
Why?
|
| Surgicenters | 1 | 2015 | 50 | 0.120 |
Why?
|
| Urinary Tract Infections | 1 | 2021 | 806 | 0.120 |
Why?
|
| Costs and Cost Analysis | 2 | 2018 | 1670 | 0.120 |
Why?
|
| Acetaminophen | 2 | 2016 | 556 | 0.120 |
Why?
|
| Infant Care | 1 | 2016 | 182 | 0.120 |
Why?
|
| Age Factors | 4 | 2019 | 18478 | 0.110 |
Why?
|
| Anxiety | 2 | 2012 | 4655 | 0.110 |
Why?
|
| Child, Preschool | 14 | 2019 | 42623 | 0.110 |
Why?
|
| Administration, Topical | 1 | 2016 | 707 | 0.110 |
Why?
|
| Touch | 1 | 2016 | 316 | 0.110 |
Why?
|
| Emergency Medical Services | 3 | 2020 | 1948 | 0.110 |
Why?
|
| Patient Positioning | 1 | 2016 | 332 | 0.110 |
Why?
|
| Sweetening Agents | 1 | 2016 | 290 | 0.110 |
Why?
|
| Analgesics | 2 | 2010 | 1070 | 0.100 |
Why?
|
| Airway Obstruction | 1 | 1997 | 672 | 0.100 |
Why?
|
| Obstetrics | 1 | 2019 | 676 | 0.100 |
Why?
|
| Canada | 1 | 2017 | 2143 | 0.100 |
Why?
|
| Acoustic Stimulation | 1 | 2016 | 1253 | 0.090 |
Why?
|
| History, 21st Century | 1 | 2017 | 1575 | 0.090 |
Why?
|
| Critical Illness | 1 | 2023 | 2754 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2000 | 2279 | 0.090 |
Why?
|
| Body Size | 1 | 2013 | 463 | 0.090 |
Why?
|
| Respiration | 1 | 1997 | 1667 | 0.090 |
Why?
|
| Guideline Adherence | 1 | 2000 | 2239 | 0.090 |
Why?
|
| Replantation | 1 | 2011 | 145 | 0.080 |
Why?
|
| Health Care Surveys | 1 | 2017 | 2437 | 0.080 |
Why?
|
| Respiration, Artificial | 2 | 2023 | 2723 | 0.080 |
Why?
|
| Monitoring, Intraoperative | 1 | 2016 | 952 | 0.080 |
Why?
|
| Nerve Block | 1 | 2016 | 711 | 0.080 |
Why?
|
| Photic Stimulation | 1 | 2016 | 2005 | 0.080 |
Why?
|
| Ureteral Obstruction | 1 | 2011 | 297 | 0.080 |
Why?
|
| Vesico-Ureteral Reflux | 2 | 2011 | 433 | 0.080 |
Why?
|
| Opioid-Related Disorders | 1 | 2013 | 2188 | 0.080 |
Why?
|
| Ureter | 1 | 2011 | 370 | 0.080 |
Why?
|
| Stress, Physiological | 1 | 2016 | 1409 | 0.080 |
Why?
|
| Emergency Service, Hospital | 3 | 2020 | 7956 | 0.080 |
Why?
|
| Quality Indicators, Health Care | 1 | 2018 | 1813 | 0.070 |
Why?
|
| Ketorolac | 2 | 2000 | 95 | 0.070 |
Why?
|
| Breast Feeding | 1 | 2016 | 1365 | 0.070 |
Why?
|
| Parents | 3 | 2021 | 3596 | 0.070 |
Why?
|
| Education, Medical, Continuing | 1 | 2013 | 829 | 0.070 |
Why?
|
| Antitussive Agents | 1 | 2016 | 18 | 0.070 |
Why?
|
| Cicatrix | 1 | 2012 | 799 | 0.070 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2016 | 108 | 0.070 |
Why?
|
| Electrophoresis | 1 | 2005 | 226 | 0.060 |
Why?
|
| Skin Absorption | 1 | 2005 | 96 | 0.060 |
Why?
|
| Treatment Outcome | 6 | 2019 | 65409 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 3708 | 0.060 |
Why?
|
| Communication | 1 | 2019 | 3910 | 0.060 |
Why?
|
| Adolescent | 10 | 2021 | 89168 | 0.060 |
Why?
|
| Glucose | 1 | 2016 | 4355 | 0.060 |
Why?
|
| Pharmacogenetics | 1 | 2016 | 677 | 0.050 |
Why?
|
| Male | 15 | 2019 | 364781 | 0.050 |
Why?
|
| Dosage Forms | 1 | 2021 | 56 | 0.050 |
Why?
|
| Drug Storage | 1 | 2021 | 52 | 0.050 |
Why?
|
| Pamphlets | 1 | 2021 | 71 | 0.050 |
Why?
|
| Ureterostomy | 1 | 2000 | 18 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2004 | 3922 | 0.040 |
Why?
|
| Nonprescription Drugs | 1 | 2021 | 119 | 0.040 |
Why?
|
| Sciatic Nerve | 1 | 2004 | 628 | 0.040 |
Why?
|
| Cystostomy | 1 | 2000 | 25 | 0.040 |
Why?
|
| 4-Butyrolactone | 1 | 2000 | 61 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 3438 | 0.040 |
Why?
|
| Spasm | 1 | 2000 | 131 | 0.040 |
Why?
|
| Medication Reconciliation | 1 | 2021 | 153 | 0.040 |
Why?
|
| Catheters, Indwelling | 1 | 2002 | 436 | 0.040 |
Why?
|
| Urinary Bladder Diseases | 1 | 2000 | 167 | 0.040 |
Why?
|
| Solvents | 1 | 2000 | 298 | 0.040 |
Why?
|
| Muscle Relaxants, Central | 1 | 2010 | 93 | 0.040 |
Why?
|
| Female | 14 | 2019 | 396943 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2019 | 54914 | 0.040 |
Why?
|
| Prodrugs | 1 | 2000 | 274 | 0.040 |
Why?
|
| Communication Barriers | 1 | 2021 | 419 | 0.040 |
Why?
|
| Mitochondrial Myopathies | 1 | 1997 | 50 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2013 | 4841 | 0.030 |
Why?
|
| Latex | 1 | 1996 | 49 | 0.030 |
Why?
|
| Pregnancy | 1 | 2019 | 30179 | 0.030 |
Why?
|
| Capnography | 1 | 1997 | 91 | 0.030 |
Why?
|
| Medication Systems | 1 | 1996 | 31 | 0.030 |
Why?
|
| Hydromorphone | 1 | 1996 | 70 | 0.030 |
Why?
|
| Syringes | 1 | 1996 | 58 | 0.030 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 1996 | 117 | 0.030 |
Why?
|
| Health Literacy | 1 | 2021 | 467 | 0.030 |
Why?
|
| Pharmacy Service, Hospital | 1 | 1996 | 134 | 0.030 |
Why?
|
| Tromethamine | 1 | 1995 | 31 | 0.030 |
Why?
|
| Bleeding Time | 1 | 1995 | 83 | 0.030 |
Why?
|
| Cholecystectomy | 1 | 1997 | 409 | 0.030 |
Why?
|
| Prilocaine | 1 | 2004 | 21 | 0.030 |
Why?
|
| Tetracaine | 1 | 2004 | 34 | 0.030 |
Why?
|
| Anesthetics, Combined | 1 | 2004 | 43 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2000 | 1444 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2000 | 6242 | 0.030 |
Why?
|
| Information Systems | 1 | 1996 | 397 | 0.030 |
Why?
|
| Young Adult | 3 | 2017 | 60045 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 1996 | 1379 | 0.030 |
Why?
|
| Respiration Disorders | 1 | 1997 | 367 | 0.030 |
Why?
|
| Mucous Membrane | 1 | 1996 | 660 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 8201 | 0.030 |
Why?
|
| Heart Defects, Congenital | 1 | 2010 | 4713 | 0.030 |
Why?
|
| Postoperative Hemorrhage | 1 | 1996 | 420 | 0.030 |
Why?
|
| Language | 1 | 2021 | 1557 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 10784 | 0.020 |
Why?
|
| Retrospective Studies | 6 | 2013 | 81834 | 0.020 |
Why?
|
| Postoperative Complications | 4 | 2013 | 15880 | 0.020 |
Why?
|
| Genotype | 1 | 2016 | 13047 | 0.020 |
Why?
|
| Respiratory Insufficiency | 1 | 2000 | 1244 | 0.020 |
Why?
|
| Safety | 1 | 1996 | 1159 | 0.020 |
Why?
|
| Tonsillectomy | 1 | 1995 | 278 | 0.020 |
Why?
|
| Informed Consent | 1 | 2018 | 1012 | 0.020 |
Why?
|
| Lidocaine | 1 | 2004 | 545 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2016 | 6610 | 0.020 |
Why?
|
| Epinephrine | 1 | 2004 | 795 | 0.020 |
Why?
|
| Radiography | 1 | 2002 | 6995 | 0.020 |
Why?
|
| Esthetics | 1 | 2012 | 329 | 0.020 |
Why?
|
| Cost Savings | 1 | 1996 | 916 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1997 | 1439 | 0.020 |
Why?
|
| Laparotomy | 1 | 2012 | 459 | 0.020 |
Why?
|
| Withholding Treatment | 1 | 2004 | 621 | 0.020 |
Why?
|
| Resuscitation | 1 | 2004 | 680 | 0.020 |
Why?
|
| Animals | 2 | 2016 | 169418 | 0.020 |
Why?
|
| Caregivers | 1 | 2021 | 2302 | 0.020 |
Why?
|
| Feedback | 1 | 2013 | 794 | 0.020 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1996 | 1126 | 0.020 |
Why?
|
| Length of Stay | 2 | 2013 | 6521 | 0.020 |
Why?
|
| Brain Diseases | 1 | 1997 | 1553 | 0.020 |
Why?
|
| Internet | 1 | 2000 | 3123 | 0.020 |
Why?
|
| Drug Costs | 1 | 1996 | 1196 | 0.020 |
Why?
|
| Rats | 1 | 2004 | 23839 | 0.020 |
Why?
|
| Heart Arrest | 1 | 2018 | 1516 | 0.020 |
Why?
|
| Drug Hypersensitivity | 1 | 1996 | 922 | 0.020 |
Why?
|
| Demography | 1 | 2012 | 1643 | 0.020 |
Why?
|
| Peritoneum | 1 | 2008 | 231 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2012 | 2932 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 2863 | 0.020 |
Why?
|
| Hypersensitivity | 1 | 1996 | 1172 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2012 | 4538 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2004 | 4041 | 0.020 |
Why?
|
| Program Development | 1 | 2013 | 1296 | 0.020 |
Why?
|
| Acute Disease | 1 | 1997 | 7246 | 0.020 |
Why?
|
| Perception | 1 | 2012 | 1207 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2001 | 6309 | 0.020 |
Why?
|
| Logistic Models | 1 | 2000 | 13324 | 0.020 |
Why?
|
| Educational Measurement | 1 | 2013 | 1256 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 20231 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 1996 | 2102 | 0.020 |
Why?
|
| Data Collection | 1 | 2004 | 3329 | 0.020 |
Why?
|
| Emergency Medicine | 1 | 2004 | 1222 | 0.020 |
Why?
|
| Patient Preference | 1 | 2012 | 948 | 0.020 |
Why?
|
| Hospitals | 1 | 2018 | 3906 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2013 | 2508 | 0.010 |
Why?
|
| Decision Making | 1 | 2018 | 3961 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2013 | 5308 | 0.010 |
Why?
|
| Chloral Hydrate | 1 | 2001 | 28 | 0.010 |
Why?
|
| Wound Healing | 1 | 2012 | 2819 | 0.010 |
Why?
|
| Recurrence | 1 | 1993 | 8510 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2012 | 3484 | 0.010 |
Why?
|
| Curriculum | 1 | 2013 | 3778 | 0.010 |
Why?
|
| Double-Blind Method | 3 | 2000 | 12450 | 0.010 |
Why?
|
| Incidence | 1 | 1996 | 21552 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1993 | 9382 | 0.010 |
Why?
|
| Meperidine | 1 | 1997 | 38 | 0.010 |
Why?
|
| Promethazine | 1 | 1997 | 29 | 0.010 |
Why?
|
| Chlorpromazine | 1 | 1997 | 111 | 0.010 |
Why?
|
| Therapeutic Equivalency | 1 | 1996 | 134 | 0.010 |
Why?
|
| Midazolam | 1 | 1997 | 267 | 0.010 |
Why?
|
| Ketorolac Tromethamine | 1 | 1995 | 21 | 0.010 |
Why?
|
| Oxidative Phosphorylation | 1 | 1997 | 501 | 0.010 |
Why?
|
| Narcotics | 1 | 1997 | 337 | 0.010 |
Why?
|
| Hemostasis, Surgical | 1 | 1995 | 127 | 0.010 |
Why?
|
| Time Factors | 2 | 2011 | 40271 | 0.010 |
Why?
|
| Fentanyl | 1 | 1997 | 450 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2011 | 22293 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 1997 | 1152 | 0.010 |
Why?
|
| Death | 1 | 1997 | 683 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 26351 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1997 | 2079 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 1996 | 2103 | 0.010 |
Why?
|
| Inflammation | 1 | 1996 | 10865 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1997 | 36840 | 0.000 |
Why?
|